INTERPACE BIOSCIENCES, INC. (IDXG)
About INTERPACE BIOSCIENCES, INC.
INTERPACE BIOSCIENCES INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $38.7M
- Net income
- $24.6M
- Total assets
- $33.8M
- Gross margin
- 33.1%
- Operating margin
- -80.5%
- Net margin
- -81.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $32.4M
- Cost of revenue
- $21.7M
- Gross profit
- $10.7M
- Operating expenses
- $36.8M
- Operating income
- -$26.1M
- Income tax
- $53.0K
- Net income
- -$26.5M
Balance sheet
- Total assets
- $45.7M
- Current assets
- $14.1M
- Total liabilities
- $28.2M
- Current liabilities
- $18.2M
- Shareholders’ equity
- -$29.1M
Cash flow
- Operating cash flow
- -$14.0M
- Investing cash flow
- -$1.6M
- Financing cash flow
- $16.6M
- Net cash flow
- $1.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Interpace Biosciences, Inc. (IDXG) Stock Price
- Profitable — net income of $24.6M in FY2025.
- Revenue grew 148% from FY2016 to FY2020.
- Gross margin of 33.1%, net margin -81.6%.
- Trading 37% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review INTERPACE BIOSCIENCES, INC..
Write a review
News about INTERPACE BIOSCIENCES, INC.
News & sentiment via Polygon.io
Interpace Biosciences, Inc.: frequently asked questions
Is Interpace Biosciences, Inc. an American company?
Interpace Biosciences, Inc. is a US-based company headquartered in Parsippany, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Interpace Biosciences, Inc. headquartered?
Interpace Biosciences, Inc. is headquartered in Parsippany, New Jersey, United States.
Is Interpace Biosciences, Inc. publicly traded?
Yes — Interpace Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol IDXG on the OTC.
What does Interpace Biosciences, Inc. do?
Interpace Biosciences, Inc. is an American Medical Devices company in the Health & Beauty sector.